How has been the historical performance of Rajputana Bio.?

Answer:The historical performance of Rajputana Bio shows a positive trend in key financial metrics over the past year. Breakdown: In the fiscal year ending March 2025, Rajputana Bio reported net sales of 67.31 crore, an increase from 53.46 crore in March 2024. The total operating income also rose to 67.31 crore from 53.46 crore, while total expenditure increased to 58.37 crore from 45.75 crore. This resulted in an operating profit (PBDIT) of 10.23 crore, up from 7.93 crore the previous year. Profit before tax improved to 7.53 crore from 6.14 crore, leading to a profit after tax of 5.92 crore, compared to 4.56 crore in the prior year. The company’s earnings per share slightly decreased to 8.42 from 8.89, while the PAT margin improved to 8.8% from 8.53%. On the balance sheet, total assets grew to 60.49 crore from 42.30 crore, with total liabilities also increasing to 60.49 crore from 42.30 crore. Cash flow from operating activities showed a negative trend at -15.00 crore, though financing activities provided a net inflow of 15.00 crore. Overall, Rajputana Bio's financial performance indicates growth in sales and profits, despite challenges in cash flow management.